scispace - formally typeset
Journal ArticleDOI

Low adiponectin levels at baseline and decreasing adiponectin levels over 10 years of follow-up predict risk of the metabolic syndrome.

Reads0
Chats0
TLDR
Low plasma adiponectin levels at baseline and decreasing adiponECTin levels during follow-up are both associated with an increased risk of MetS.
About
This article is published in Diabetes & Metabolism.The article was published on 2017-04-01. It has received 32 citations till now. The article focuses on the topics: Adiponectin & Adipokine.

read more

Citations
More filters
Journal ArticleDOI

Metabolic Syndrome Pathophysiology and Predisposing Factors.

TL;DR: The purpose of this review is to provide an overview from the syndrome epidemiology, costs, and main etiological traits from its relationship with unhealthy diet patterns and sedentary lifestyles.
Journal ArticleDOI

Adiponectin and Cardiovascular Risk. From Pathophysiology to Clinic: Focus on Children and Adolescents

TL;DR: The aim of this review is to summarize the evidence on the relationship between Ad, obesity, metabolic alterations and hypertension in children and adolescents, and to address the possibility that Ad represents an early marker of cardiovascular risk in pediatric subjects.
Journal ArticleDOI

Meta-Analysis of Adiponectin as a Biomarker for the Detection of Metabolic Syndrome.

TL;DR: Adiponectin measurement might have potential benefits in the detection of metabolic syndrome and factors that affect insulin resistance should be considered for adjustment in future assessments.
Journal ArticleDOI

The association between serum adiponectin and 3-month outcome after ischemic stroke

TL;DR: The results show that high adiponectin is associated with stroke severity and support the hypothesis that adip onectin can be serve as a biomarker of poor outcome after stroke, independent of baseline variables.
References
More filters
Journal ArticleDOI

Definition of Metabolic Syndrome Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition

TL;DR: Although ATP III identified CVD as the primary clinical outcome of the metabolic syndrome, most people with this syndrome have insulin resistance, which confers increased risk for type 2 diabetes, when diabetes becomes clinically apparent, CVD risk rises sharply.
Journal ArticleDOI

Adipose tissue as an endocrine organ.

TL;DR: These proteins commonly known as adipokines are central to the dynamic control of energy metabolism, communicating the nutrient status of the organism with the tissues responsible for controlling both energy intake and expenditure as well as insulin sensitivity.
Journal ArticleDOI

Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients

TL;DR: Results suggest that the decreased plasma adiponectin concentrations in diabetes may be an indicator of macroangiopathy, and weight reduction significantly elevated plasma adip onectin levels in the diabetic subjects as well as the nondiabetic subjects.
Journal ArticleDOI

Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome

TL;DR: The pathophysiology of adiponectin and adiponECTin receptors in insulin resistance, diabetes, and the metabolic syndrome is described and potential versatile therapeutic targets to combat obesity-linked diseases characterized by insulin resistance are described.
Journal ArticleDOI

The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis.

TL;DR: A systematic review and meta-analysis of the cardiovascular risk associated with the metabolic syndrome as defined by the 2001 NCEP and 2004 revised National Cholesterol Education Program definitions found the syndrome is associated with a 2-fold increase in cardiovascular outcomes and a 1.5- fold increase in all-cause mortality.
Related Papers (5)